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Abstract
I will refer in this paper to difficulties in research in environmental causes of cancer using as examples research on
dioxins and on drinking water disinfection by-products (DBPs) that have created considerable controversy in the
scientific and wider community. Dioxins are highly toxic chemicals that are animal carcinogens. For many years,
evaluation of the carcinogenicity of dioxins in humans was based on case-control or registry based studies. The
development of methods to measure dioxins in blood indicated that these studies suffered from extreme exposure
misclassification. The conduct of large cohort studies of workers with widely contrasted exposures together with
the use of biomarkers and models for exposure assessment, led to convincing evidence on the carcinogenicity of
dioxins in humans. The high toxicity of a few dioxin congeners, the availability of a scheme to characterize the
toxicity of a mixture of dioxins and related compounds and the long half-life of these compounds facilitated
epidemiological research. Contrary to dioxins, trihalomethanes (THMs) and most of the hundreds of DBPs in
drinking water are chemicals of low toxicity. For more than 15 years, the main evidence on the carcinogenicity of
DBPs was through ecological or death certificate studies. More recent studies based on individual assessment
confirmed increases in bladder cancer risk. However even those studies ignored the toxicological evidence on the
importance of routes of exposure to DBPs other than ingestion and, probably, underestimated the risk. Persistence
of weak study designs together with delays in advanced exposure assessment models led to delays in confirming
early evidence on the carcinogenicity of DBPs. The evaluation of only a few chemicals when exposure is to a
complex mixture remains a major problem in exposure assessment for DBPs. The success of epidemiological
studies in identifying increased risks lies primarily on the wide contrast of exposure to DBPs in the general
population that overcomes the significant exposure misclassification. Exposure assessment has been the Achilles
heel for studies on dioxins and DBPs and cancer. The combination of powerful study designs, advanced exposure
assessment together with a better understanding of mechanisms of disease and the use of biomarkers of
exposure, led to the strengthening of the epidemiological evidence.
Background
The significant and rapid changes in cancer incidence in
the last decades can only be attributed to equally large
changes in population exposure to environmental fac-
tors. Several environmental exposures are known to
cause cancer. Frequently, however, hypotheses linger on
for years or decades without being able to provide con-
vincing evidence in one or the other side. This has led
to serious criticisms towards environmental epidemiol-
ogy [1].
The environment defined in a wide sense refers to all
factors that are not genetic, and includes lifestyle factors
such as tobacco smoking, biological agents such a HPV,
medicaments, nutrition, occupational exposures and
other. Environment in a more restricted definition
includes all non-genetic factors that are not directly
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choices of the persons. Using the restricted definition
active smoking should not be classified as environmen-
tal, while second-hand-smoke should. This rather
ambiguous definition complicates the attribution of cau-
sation to specific risk factors. For example, use of hair
dyes is generally considered as lifestyle while exposure
to phthalates through the use of hairsprays, is consid-
ered environmental. In addition, what frequently are
defined as personal choices, for example whether you
smoke, are dependent on a variety of factors related to
the social and environmental milieu of each person.
With these limitations in mind, I will refer in this paper
to environmental causes of cancer using the restricted
definition of environment, identify major problems in
environmental cancer research and discuss how these
problems have been overcome. I will use as examples
cancer research on dioxins and on drinking water disin-
fection by-products that have created considerable con-
troversy in the scientific and wider community.
Environmental causes of cancer
Doll and Peto [2] in their influential and clairvoyant
review on the causes of cancer identified a small list of
environmental exposures. Their review incorporated
environmental exposures that were investigated at that
time and that were relatively few. Among the main fac-
tors reviewed were air-pollution (PAHs, and arsenic,
asbestos, radioactive elements), drinking water (chlorina-
tion and fluoridation), food pollution (pesticides), indus-
trial products (hair dyes and other) and geophysical
factors (ionizing and solar radiation). Their estimate on
the risk attributable to these exposures (the proportion
of disease caused by these factors) is unclear and is pos-
sibly less than 3% to 4%. Research since the early 1980s
has provided extensive new evidence on environmental
exposures associated with cancer (Table 1). Since the
1980s, we have accumulated conclusive proofs on the
carcinogenicity of some of the exposures shown in
Table 1 such as arsenic in water [3]. Some major expo-
sures currently investigated did not occur at the time of
the review by Doll & Peto, as is for example the popula-
tion exposure to radiofrequencies through the massive
use of mobile phones. There are no generally accepted
comprehensive overall estimates of the attributable risk
for environmental cancer. Estimates for specific risk fac-
tors differ considerably [4,5].
The volume of research in environmental causes of
cancer has been growing. Time trends in research in
occupational, environmental and genetic cancer epide-
miology are shown in Figure 1 based on data retrieved
from PubMed for the period 1995-2009 (no language
limitations). Publications in occupational cancer epide-
miology have remained stable to around 75 per year,
though this means that there has been a proportional
decline given the overall increasing time trends in scien-
tific publications. Publications in environment cancer
epidemiology have doubled from around 150 publica-
tions per year in the mid 1990s to approximately 290 fif-
teen years later. This increase is similar to the average
increase in all scientific publications listed in PubMed
that doubled during these 15 years from around 430,000
in 1995 to 815,000 in 2008. The increase of papers in
environmental cancer epidemiology is small compared
to an unprecedented increase in genetic cancer epide-
miology that quadrupled in these fifteen years with an
average of around 1000 papers per year at end of the
period.
Whether the lack of a major increase in publications
in environmental cancer as compared to genetic cancer
epidemiology should be evaluated as an expression of
crisis in this field at a time when there is continuous
and growing interest on the environment in general, is
outside the scope of this paper. Whatever the overall
evaluation may be, it is clear that certain of the environ-
mental causes of cancer examined have created consid-
erable controversy, e.g. extremely low frequency
electromagnetic fields (EMF ELF), mobile phones, diox-
ins, and other and have frequently not led to solid con-
clusions and public health action, or led to action after
long delays.
Dioxins and cancer: the epidemiological evidence
Dioxins and related compounds are unwanted chemical
agents that are produced in several industrial processes
such as the incineration of municipal waste, processes in
the pulp and paper industry or the metal recycling
industry. In the 1970s, dioxins were contaminants of the
widely used phenoxy herbicides such as Agent Orange.
There exist 210 polychlorinated dioxin and furan
Table 1 Environmental exposures associated with cancer.
The strength of the association differs and convincing
evidence is available only for some of the exposures
￿ Air pollutants
– Outdoor air e.g. particulates, PAHs, asbestos, erionite, benzene
– Indoor air e.g. second-hand-smoke, combustion wood, combustion
coal, high temperature frying, formaldehyde
￿ Water contaminants e.g. arsenic, disinfection byproducts, nitrates
￿ Persistent Organic Pollutants, e.g. dioxins, PCBs, endocrine disrupters,
food contaminants
￿ Metals, e.g. arsenic, chromiumVI, cadmium
￿ Industrial products e.g. hair dyes
￿ Radiations
– Ionising (radon)
– Solar radiation
– Electromagnetic Fields (EMF), extremely low frequency and
radiofrequencies
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is the most toxic compound of this family of structurally
related chemicals that have a common mechanism of
action and are believed to induce the same spectrum of
health related effects. TCDD is considered by the IARC
as a human carcinogen since 1997 [6] and it was
recently re-evaluated and again classified as Group 1
carcinogen [7] based on sufficient evidence on both
humans and animals. The WHO/FAO (World Health
Organization/ Food and Agriculture Organization)
recommended in 2002 [8] that human ingestion in
adults should stay below a limit of 70 pg/kg weight/
month that corresponds to approximately 2pg/kg per
day. This limit is relatively close to the average intake of
several populations although in recent years consider-
able decreases have been achieved in several industrial
countries such as the USA and Germany. Critical effects
used to define this Tolerable Daily Intake (TDI) were
effects on the reproductive, developmental and endo-
crine systems. Cancer effects in animals are multiple
and well characterized but appear at higher doses. Mod-
elling of epidemiological data have identified increased
cancer risks at doses only few times higher than the
TDI set by WHO/FAO [9]. Exposure to humans is
nearly entirely through the diet, particularly milk and
other dairy products, fish and meat. The case of dioxins
is of interest for research because it refers to a highly
toxic chemical that produces multiple cancers in ani-
mals for which, however, epidemiological studies had
serious difficulties in identifying cancer risk in humans.
This led for a long period to a controversy that was
finally solved in the wider scientific community (with
few exceptions of sceptics) when appropriate study
designs and appropriate exposure methods based on
combination of modelling and biomarkers provided
solid evidence [10].
The similarity of action of different dioxins, has led to
the development of a relative potency-ranking scheme
using toxic equivalent factors (TEQ). The total dioxin-
like activity of a complex mixture is expressed as the
weighted sum of all the dioxin-like chemicals [11]. This
scheme includes 17 dioxins and furans and a small
number of PCBs that show dioxin-like activity. Dioxins
are lipophilic, are slowly metabolized and eliminated,
and tend to bioaccumulate. The half-life of different
compounds differs, but the TEQs of the mixtures to
which humans are exposed are usually driven by just a
few of these compounds. The half-life of TCDD has
been estimated in humans to be between 7 and 8 years.
Most of the effects of dioxins are believed to be
mediated through the Ah receptor that is highly con-
served in different species. Various dioxin effects includ-
ing enzyme induction, immunotoxicity, developmental
effects, tend to be similar irrespective of whether the
exposure is acute or chronic and this probably reflects
the fact that it is the tissue concentration which is
directly associated with the response.
The epidemiological studies on dioxins include those of
industrial exposures in workers producing phenoxy herbi-
cide and chlorophenols, studies of the population exposed
in the industrial accident in Seveso, studies of subjects
exposed during herbicide application particularly,
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Figure 1 Time trends in publications in occupational, environmental and genetic cancer epidemiology 1995-2009 (no limits, hits retrieved from
PubMed).
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in Vietnam, commercial application cohorts, and commu-
nity based studies (case-control studies).
For many years the discussion on the carcinogenicity
of dioxins in humans were based on results from com-
munity-based studies or on studies from registries
including pesticide applicators. Findings on cancer risk
among subjects evaluated in community based studies
and sprayer applicator studies are contradictory. The
large discrepancies observed are mostly due to exposure
misclassification, since most subjects classified as
exposed in those studies had probably very similar or
only slightly elevated levels of TCDD compared to those
classified as non-exposed.
Figure 2, shows the ORs for around 15 case-control
studies evaluating exposure to phenoxy herbicides,
chlorophenols and dioxins and soft-tissue sarcoma risk.
A similar pattern is observed for lymphomas. The first
study on phenoxy herbicides and soft-tissue sarcoma
that is a rare tumour in adults was done in northern
Sweden [12]. Although the methods of that study were
criticized, findings were later replicated in other studies
in Sweden [13]. However, when evaluating all available
studies, the overall picture of risk was far from being
conclusive with many discrepant findings (Figure 2).
This created significant scepticism in the scientific
community.
The difficulties in evaluating exposure in users of pes-
ticides and long-term effects are well known (14). Until
recently, the limited knowledge on effects of pesticides
on cancer comes mostly from industrial cohorts of
workers producing a specific compound rather than
from studies of users. The main problem in studies on
users of pesticides, professional or the general public is
the extreme difficulty in identifying exposure retrospec-
tively given the variety of compounds used in agriculture
and the lack of knowledge of specific compounds by the
users. Although several elaborate methods have been
developed to identify exposure to pesticides in case-
control studies [14], this remains a very difficult task. If
exposure to a parent compound (pesticide) is difficult to
evaluate, it is practically impossible to evaluate exposure
to a contaminant of a pesticide, such as dioxins that are
contaminants of specific phenoxy herbicides and
chlorophenols.
The development of an assay to measure dioxins in
blood lipids, allowed an evaluation of exposure to these
compounds in the worker and general populations. Ana-
lyses among professional sprayers (applicators) of phe-
noxy herbicides [15] showed that their exposure was far
lower than that of production workers of the same com-
pounds. In sprayers of phenoxy herbicides in New
Zealand, it was shown that only prolonged exposures of
more than 10 years would unequivocally increase TCDD
levels of the sprayers to levels above background (Figure
3). This meant that the assessments done in case-
control studies grossly misclassified exposure to dioxins.
In many studies, the cut-off to identify someone as
exposed to dioxins would have been the use of phenoxy
herbicides for periods as short as 1 week or 1 month.
Studies using measurements of TCDD in blood indi-
cated that this exposure would not be associated with
any measurable increase in exposure to dioxins.
The development of assays to measure TCDD and
other dioxins and the decision to study prospectively
industrial cohorts and accidentally exposed populations
(Seveso) gave conclusive findings concerning the carci-
nogenicity of dioxins. There has been considerable effort
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Figure 2 Odds Ratios for soft-tissue sarcoma and exposure to phenoxy herbicides, chlorophenols and dioxins. 15 case-control studies (adapted
from E Johnson 1993, ref. [34]).
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which are exposed from 10 to 1000 times higher levels
of TCDD than the general population. Cancer mortality
was invariably increased in alli n d u s t r i a lc o h o r t se x a m -
ined (Table 2). Statistically significant moderate
increases of the order of 40% to 50% were observed
among the exposed subcohorts of these populations and
higher risks were observed for subjects with the highest
exposures. Positive linear trends in risk were found with
increasing exposure for all cancers combined and for
some specific cancers [16]. Increased risks with time
since first exposure were observed in those studies that
evaluated latency [17].
In examining the findings on cancer risk from the
most informative epidemiological studies (informative in
terms of validity of exposure assessment and inclusion
of subjects with high dioxin exposure) a number of
issues should be noted. Low excess risks for all neo-
plasms combined were found in all industrial cohort
studies with adequate exposure assessment that applied
biomarkers and modelling. These excess risks were
highly statistically significant and an effect of chance
can be excluded. The risk tended to be higher for those
workers with the highest exposures. Risk for several spe-
cific cancers were increased in some of these studies
(lymphomas, multiple myeloma, soft-tissue sarcoma,
lung cancer, liver cancer, breast cancer, testicular can-
cer, endometrial) but consistent findings were only
found (apart from all neoplasms combined), for lung
cancer, lymphomas and soft-tissue sarcoma [7]. At pre-
sent, the real dilemmas are not whether dioxins are or
not carcinogens, but rather on the quantification of the
risk associated with the very low-level exposure of the
general population.
Dioxins and cancer in humans, why did it take so
long to conclude?
The first case-control studies were conducted in the late
1970s [12]. It was only in 1997 that IARC classified
TCDD as human carcinogen based on limited evidence
in humans and very strong evidence in animals together
with mechanistic information. At that time, even though
IARC classified dioxins as carcinogens there was wide-
spread discussion about whether this classification was
appropriate. It was only until 2009 that IARC in a new
evaluation classified TCDD as carcinogen also based on
sufficient human evidence. In addition, in 2009 a num-
ber of specific sites were identified to be specifically
related to TCDD apart from an overall cancer increase.
The long delay in providing conclusive evidence was
due to wrong study design and to extreme exposure
misclassification. Notwithstanding the importance of the
first case-control studies in identifying the problem, this
design appeared inadequate to identify increased risks in
Figure 3 Concentration of TCDD in serum of New Zealand professional sprayers (applicators) in relation to total months spent spraying 2, 4, 5-T
(Smith et al, JNCI. 1992, ref. [15])
Table 2 Mortality from all neoplasms in selected
industrial cohorts with high exposure levels to
PolyChlorinated Dibenzo Dioxins and Furans (adapted
from IARC 1997, ref [6])
Reference No. deaths SMR (95% CI)
IARC International cohort
Kogevinas et al 1997, ref [29] 394 1.2 (1.1-1.3)
Industrial populations (high exposure sub-cohorts)
Steenland et al 1999, ref [30] 40 1.6 (1.2-1.8)
Becher et al 1996, ref [31] 105 1.3 (1.0-1.5)
Hooiveld et al 1997, ref [32] 51 1.5 (1.1-1.9)
Ott & Zober 1996, ref [33] 18 1.9 (1.1-3.0)
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such as dioxins. The reason was that differences in
exposure to TCDD in the general population can be
expected to be small with only very few subjects having
high exposures and the tools used in the case-control
studies are inadequate to identify these differences. This
does not mean that exposure even at low levels cannot
produce cancer; it simply means that the research
design used could not correctly identify these risks.
Extreme exposure misclassification occurred due to very
low exposure levels and the lack of contrast in exposure
of the general population. Use of contaminated phenoxy
herbicides in the backyard may result to exposure to
dioxins, but this is minimal and impossible to capture
with questionnaires.
We were finally successful in identifying the cancer
risks associated with TCDD because of (i) application of
appropriate designs and exposure-assessment methods;
and (ii) some inherent characteristics of dioxins that
facilitated the evaluation of the risks.
The research aspects concerning the success are
mainly the conduct cohort studies in populations that
included subjects with widely contrasted levels of expo-
sure to TCDD and the development of biomarker that
allowed measurement of levels of TCDD and other
dioxin –like compounds in serum samples of large
populations.
Some of the characteristics of the toxicity of these
compounds also made possible this research. The first is
that some of the dioxins and furans are highly toxic che-
micals and TCDD is among the most toxic compounds
tested in the laboratory. In addition, for dioxins we have
au s a b l es c h e m ef o rt h em e a s u r e m e n to ft h et o x i c i t yo f
a mixture that has been developed based on extensive
information on the toxicity of many of the individual
dioxins, furans and dioxin-like PCBs. Given that our
exposure is to mixtures rather than to single chemicals,
exposure assessment should be done on the mixture
rather than on one single chemical. The TEQ system
allowed this evaluation of total toxicity. In this case, the
identification of a small set of very toxic chemicals can
characterize well the toxicity of a mixture. The second
characteristic that helped research (and that relates to
the high overall toxic effects of these chemicals) is their
long half-life that for TCDD is around 7 years. Chemi-
cals with long half-life can be measured many years
after exposure has stopped and still allow an evaluation
of level of exposure in the past through the use of
models.
Drinking water disinfection by-products and
cancer in humans
Drinking water disinfectants include highly reactive
molecules that generate undesired compounds through
reaction with organic matter. These disinfection by-
products (DBP) constitute complex mixtures of chemical
species with different properties. Chlorine, the most
widely used disinfectant for drinking water, gives rise to
trihalomethanes (THM), that in most waters are the
most prevalent DBPs. Some epidemiological studies
have shown an association between long-term exposure
to chlorination by-products and increased risk of cancer
which is supported by experimental evidence of carcino-
genicity for some of these chemicals [18]. Many of these
compounds have been shown to be genotoxic, but the
mechanisms of action are not well elucidated and few
studies have evaluated markers of genotoxicity in
humans.
THMs in drinking water were first identified in 1974.
Concerns were expressed shortly after, regarding poten-
tial health effects of these compounds given their toxi-
city in experimental animals. The first studies were
ecological comparing levels of THMs (or proxies) with
cancer mortality and suggested bladder as one of the
cancer sites associated with chlorinated water intake.
For example, a comparison of mortality in different
areas around the Mississippi river [19] indicated that
cancer mortality was higher in more urban areas and
that it was higher in areas getting water from the river
where higher levels of THMs could have been expected
(Figure 4). Several similar studies were published in the
following years and when the International Agency for
Research on Cancer evaluated chlorinated drinking
water as a potential human carcinogen in 1991 [20],
most of the available studies were ecological or death
certificate-based. These studies typically used cross-sec-
tional estimates of exposure usually around the time of
death, and were limited in their ability to adjust for
other risk factors. The methodological limitations led
Figure 4 Total cancer mortality and urbanization for parishes
without drinking water from the Mississippi (closed circles) and
those with some al all water from the Mississippi (stars). The latter
are expected to have higher exposure to THMs (from Page et al
1976, ref. [19]).
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city of chlorinated drinking water in humans was inade-
quate (group 3). After this evaluation, several studies
with improved exposure assessment at the individual
level were published. Among them, the studies of blad-
der cancer reported positive associations with chlorina-
tion by-products exposure. A meta-analysis of studies
on bladder cancer [21] with individual information on
residence and water consumption reported an increased
risk in subjects with long-term consumption of chlori-
nated drinking water. A posterior pooled analysis [22]
confirmed these findings and reported an increased risk
for levels that occurred normally in industrial societies
(Figure 5). These analyses were published about 30
years after the identification of THMs and provided the
strongest evidence for an effect of DBPs on cancer.
While ingestion considered as the main route of expo-
sure to DBPs, the high volatility and dermal permeability
of certain DBPs leads to a significant contribution of the
inhalation and dermal absorption pathways. Experimen-
tal studies have shown a significant uptake of THMs
through these routes when showering, bathing or swim-
ming in pools [23,24]. The Spanish bladder cancer study
[25] was the first study to evaluate multiple routes of
exposure by requesting detailed information on activities
such as baths, showers, swimming pool attendance that
would lead to exposure by non-ingestion routes. In this
study, THM levels were used as marker of DBP expo-
sure. An increased risk was associated with both inges-
tion and inhalation/dermal absorption, but the latter
routes led to higher contrasts in risk (Table 3). What
was further shown in this study was that subjects living
in areas with poor quality water and very high levels of
THMs tended to consume preferentially bottled water
that does not have THMs [26]. Among the subjects who
would have been classified as no- or very low-exposed
to THMs had the evaluation been focused only on
ingestion, 45% would have been classified as high or
very high exposed through showers and baths. The non-
exposed group, therefore, included subjects not exposed
by ingestion, but who were heavily exposed in showers
and baths through inhalation and dermal absorption.
There is still no consensus on the cancer risk of expo-
sure to DBPs/THM, but there is accumulating evidence
particularly for bladder cancer.
Disinfection by-products and cancer in humans,
why does it take so long to conclude?
Similar to dioxins, the difficulty in providing conclusive
evidence for an association between exposure to DBPs
and cancer in humans lies both in inherent characteris-
tics related to the toxicity of these compounds and in
issues regarding the epidemiological methods used.
Contrary to dioxins, DBPs are chemicals of low toxi-
city, at least as evaluated in experimental studies. There
are about 700 DBPs identified in drinking water and
most are in minute concentrations. Epidemiological stu-
dies have focused on THMs, because they are carcino-
genic in experimental animals and because these they
were the most prevalent DBPs in most waters. However,
short term toxicity studies indicate that THMs are not
among the most toxic DBPs compared to other chlori-
nated DBPs (e.g. MX), or to brominated and iodinated
DBPs [27]. A complication in the evaluation of the toxi-
city of mixtures of DBPs in waters is that none of the
prevalent DBP is much more toxic. The result is that
drinking waters that have a mixture of hundreds of
DBPs cannot be easily characterized for their toxicity
through the identification of one or very few specific
DBPs. As much as knowledge accumulates on the toxi-
city of numerous DBPs, it appears that the toxicity of a
water sample measured through the evaluation of THM
levels would provide only a small fraction of the total
toxicity. Mixtures have, by definition, variable
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Figure 5 Pooled analysis of case-control studies on bladder cancer
and exposure to Trihalomethanes in drinking water. Log odds ratio
for bladder cancer and average exposure to THMs (mg/L) using
natural splines (3df), both sexes (from Villanueva et al 2004, ref. [22]).
Table 3 Odds ratios (OR) and 95% confidence intervals
(CI) of bladder cancer for different indices of exposure to
disinfection by products from a hospital-based case-
control study conducted in Spain (adapted from
Villanueva et al 2007, ref. [25])
Quartiles of exposure Ingestion Inhalation/Skin absorption
OR (95%CI) OR (95%CI)
First (Lowest) 1.0 (ref) 1.0 (ref)
Second 0.9 (0.6-1.3) 1.3 (0.9-1.9)
Third 1.2 (0.8-1.7) 1.4 (0.9-2.1)
Fourth (highest) 1.4 (0.9-2.0) 1.8 (1.2-2.9)
p-value for linear trend 0.09 <0.01
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ences in water contaminants between areas have repeat-
edly been shown. Until now, there exists no toxicity
algorithm similar to that of PAHs or dioxins to calculate
toxicity of mixtures. Finally these chemicals have short
half-lives, so unless measurements in biological samples
are done immediately (e.g. in exhaled breath or in other
media) they cannot be identified per se or by measuring
metabolites. This scenario of relatively low toxicity che-
micals with short half-lives that occur in mixtures is the
norm rather than the exception in studies in environ-
mental cancer.
The problems with the epidemiological research on
DBPs related to the type of study designs used for many
years and the poor exposure assessment that was further
complicated due to the ignorance of toxicological evi-
dence on routes of exposure to DBPs. For more than 15
years, the main evidence on the carcinogenicity of DBPs
was through ecological or death certificate studies. We
now know that because of the importance of non-inges-
tion routes of exposure, the water that enters the house
may largely determine the exposure of inhabitants of a
house. Therefore, an ecological based exposure evalua-
tion may provide a less misclassified assessment com-
pared to circumstances with higher variability of
exposure within small areas. However, these studies still
carry an uncertain degree of exposure misclassification
because of the lack of detailed information of exposure
at the area and individual level, and the cross sectional
nature of the studies that usually refer to the last resi-
dence only. They have also the other problems of ecolo-
gical studies such as unmeasured confounding. Death
certificate studies share the same problems. The fact
that ecological studies indicate clearly an increase in
bladder cancer (and not of many other cancers) point to
a real effect. However, reliance only on ecological and
death certificate studies to evaluate risks that are not
very high, cannot but create distrust about the findings.
When the evidence is repeatedly based on relatively
weak study designs and no stronger evidence is pro-
vided, then unavoidably this may create distrust. The
first well-conducted individually based study was pub-
lished in the 1987 [28], and the first study to take into
account exposure in a more comprehensive way, pub-
lished in 2007 [26]. Given the widespread exposure and
the high prevalence of the cancer involved, this appears
as a gross error in research priorities: if the risk is real
then we should prevent it, and if it is not real, then we
should verify this and avoid taking measures.
Toxicological studies indicated since the late 1980s that
inhalation and dermal absorption for many DBPs were
important exposure routes. This evidence took around
10 years to reach epidemiologists and be implemented in
our protocols. This delay is probably due to the existence
of a certain compartimentation in science that compli-
cates the transmission of knowledge across scientific
areas. Inclusion of questions on different tasks that pro-
vide information on different exposure routes, make the
epidemiological assessment much more complete. As
mentioned above, not evaluating other exposure routes
may lead to the definition of persons drinking bottled
water as non-exposed while they are in reality exposed by
inhalation or dermal absorption [26]. This may lead to
considerable misclassification since areas with poor qual-
i t yw a t e ra r ef r e q u e n t l yt h o s ew h e r et h e r ei sh i g hc o n -
sumption of bottled water. The whole picture may be
more complicated since not all compounds are volatile
and not all are absorbed through the skin. The second
most common DBPS (haloacetic acids) are non-volatile
and the route of principal exposure is ingestion. In addi-
tion, these chemical are found in high concentrations in
swimming pools since they do not volatilize.
The evaluation of only a few chemicals when exposure
is to a complex mixture is problematic. In some waters,
THMs could be used as marker chemicals for the whole
mixture but this should be verified through chemical
analyses of different compounds in the water. The
hypothesis that the toxicity of the whole mixture can be
accurately estimated by measuring THMs remains an
assumption and may lead to significant misclassification.
Alternatives to this assumption are not obvious particu-
larly for long-term retrospective studies since extensive
routine measurements in water are only available for
THMs, and even these are scarce.
The main reason why significant misclassification in
exposure has not impeded several epidemiological stu-
dies to identify risks is that there are wide contrasts of
exposure in DBP levels between populations. Even sig-
nificant misclassification still allows an adequate identi-
fies populations with widely different levels of exposure
to THMs (and presumably other DBPs). In prospective
studies, the measurement of a wide range of chemicals
is feasible as also may be the use of global unspecific
tests for toxicity, such as the Comet assay or mutageni-
city in waters using the Ames test.
Future studies should be large, combine ecological and
individual information on exposure, evaluate multiple
chemicals and not only THMs and evaluate multiple
routes. In a situation of relatively low risks, even rela-
tively small improvements in exposure assessment may
make significant differences in the studies. The use of
new evidence on mechanisms of these compounds
including use of genotyping to evaluate effect modifica-
tion should be promoted.
Conclusions
In recent years, large studies have been conducted
focusing on a variety of environmental exposures. The
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Page 8 of 10identification that exposure assessment has been the
Achilles heel for studies in environmental cancer has
led to the use of more advanced techniques for expo-
sure assessment and to considerable improvements in
the evaluation of exposure. These involve the use of
classical environmental epidemiological techniques and
in recent years the use of modern techniques such as
satellite imaging etc. In addition, these advances have
gone along with more powerful statistical analyses.
Cohort studies have applied biomedical technology and
have used more extensively biomarkers of exposure.
The better understanding of mechanisms of disease has
finally allowed the development of more accurate
hypotheses. The issue of evaluating mixtures and parti-
cularly mixtures of low toxicity chemicals remains diffi-
cult to solve and certainly requires the application of
state-of-the art methods to minimize inherent difficul-
ties in the detection of risks associated with exposure
to such chemicals. It also will require extensive discus-
sion to evaluate whether modern biotechnology can
provide new methods for the characterization of this
toxicity. I used two examples of the evolution of evi-
dence on the carcinogenicity of dioxins and of water
DBPs. I showed that the combination of more powerful
study designs and more accurate exposure assessment
together with a better understanding of mechanisms of
disease and the use, in the case of dioxins, of biomar-
kers of exposure, led to the strengthening of the epide-
miological evidence.
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